Cargando…

Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer

Glucose transporter 1 (GLUT1) expression is a prognostic marker for esophageal squamous cell carcinoma (ESCC). Recent work on GLUT1 and development of specific inhibitors supports the feasibility of GLUT1 inhibition as a treatment for various cancers. The anti–proliferative effects of GLUT1‐specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawayama, Hiroshi, Ogata, Yoko, Ishimoto, Takatsugu, Mima, Kosuke, Hiyoshi, Yukiharu, Iwatsuki, Masaaki, Baba, Yoshifumi, Miyamoto, Yuji, Yoshida, Naoya, Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500964/ https://www.ncbi.nlm.nih.gov/pubmed/30861255 http://dx.doi.org/10.1111/cas.13995

Ejemplares similares

Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer
por: Kiyozumi, Yuki, et al.
Publicado: (2019)

Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020)

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis
por: Sakamoto, Yuki, et al.
Publicado: (2021)

Primary colonic well-differentiated / dedifferentiated liposarcoma of the ascending colon: a case report
por: Sawayama, Hiroshi, et al.
Publicado: (2017)

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
por: Kalikawe, Rebecca, et al.
Publicado: (2019)

Prognostic Value of Pretreatment Red Blood Cell Distribution Width in Patients With Esophageal Cancer Who Underwent Esophagectomy: A Retrospective Study
por: Yoshida, Naoya, et al.
Publicado: (2022)

Clinical Significance of Pretreatment Red Blood Cell Distribution Width as a Predictive Marker for Postoperative Morbidity After Esophagectomy for Esophageal Cancer: A Retrospective Study
por: Yoshida, Naoya, et al.
Publicado: (2021)

Multiple heterochronic gastrointestinal stromal tumors in the stomach detected 6 years after resection: a case report
por: Yasuda, Tadahito, et al.
Publicado: (2020)

Port site recurrence of esophageal adenocarcinoma after minimally invasive esophagectomy: a case report
por: Horino, Taichi, et al.
Publicado: (2020)

Laparoscopic surgery for colorectal cancer with persistent descending mesocolon
por: Hiyoshi, Yukiharu, et al.
Publicado: (2019)

Thyroid metastasis from esophageal adenocarcinoma: a case report and literature review
por: Yumoto, Shinsei, et al.
Publicado: (2019)

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?
por: Yamashita, Kohei, et al.
Publicado: (2019)

PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
por: Okadome, Kazuo, et al.
Publicado: (2021)

KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review
por: Shigaki, Hironobu, et al.
Publicado: (2012)

Synchronous NET and colorectal cancer development: a case report
por: Yumoto, Shinsei, et al.
Publicado: (2020)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications
por: Baba, Yoshifumi, et al.
Publicado: (2017)

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer
por: Baba, Yoshifumi, et al.
Publicado: (2021)

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers
por: Okadome, Kazuo, et al.
Publicado: (2020)

Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer
por: Yamashita, Kohei, et al.
Publicado: (2020)

Identification of miR-30e* Regulation of Bmi1 Expression Mediated by Tumor-Associated Macrophages in Gastrointestinal Cancer
por: Sugihara, Hidetaka, et al.
Publicado: (2013)

A case of clinical stage I gastric cancer with a schwannoma on the left supraclavicular fossa suspected as Virchow’s node metastasis
por: Hara, Yoshihiro, et al.
Publicado: (2022)

Evaluation of clinical outcomes with propensity‐score matching for colorectal cancer presenting as an oncologic emergency
por: Ogawa, Katsuhiro, et al.
Publicado: (2022)

Multiple skeletal muscle metastases from poorly differentiated gastric adenocarcinoma
por: Koga, Yuki, et al.
Publicado: (2015)

Presacral lymph node recurrence of rectal intramucosal adenocarcinoma after endoscopic mucosal resection: a case report
por: Horino, Taichi, et al.
Publicado: (2020)

Fusobacterium nucleatum in gastroenterological cancer: Evaluation of measurement methods using quantitative polymerase chain reaction and a literature review
por: Yamamura, Kensuke, et al.
Publicado: (2017)

Overall survival after recurrence in stage I–III colorectal cancer patients in accordance with the recurrence organ site and pattern
por: Sawayama, Hiroshi, et al.
Publicado: (2021)

Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)

Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients
por: Nomoto, Daichi, et al.
Publicado: (2021)

Preoperative transferrin level is a novel prognostic marker for colorectal cancer
por: Sawayama, Hiroshi, et al.
Publicado: (2021)

Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma
por: Sugihara, Hidetaka, et al.
Publicado: (2015)

Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma
por: Liu, Yang, et al.
Publicado: (2020)

UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
por: Nakamura, Kenichi, et al.
Publicado: (2016)

Essential updates 2020/2021: Colorectal diseases (benign)—Current topics in the surgical and medical treatment of benign colorectal diseases
por: Sawayama, Hiroshi, et al.
Publicado: (2022)

Precautions for avoiding pulmonary morbidity after esophagectomy
por: Yoshida, Naoya, et al.
Publicado: (2020)

Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
por: Miyamoto, Yuji, et al.
Publicado: (2015)

LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis
por: Shigaki, Hironobu, et al.
Publicado: (2012)

TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma
por: Murata, Asuka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_86rfl0ali7uietgh3303fmmjri